Armata Pharmaceuticals (ARMP) Asset Utilization Ratio (2014 - 2020)

Armata Pharmaceuticals (ARMP) reported Asset Utilization Ratio of 0.0 for Q2 2020, down 72.9% sequentially from 0.01 in Q4 2017.

Armata Pharmaceuticals (ARMP) Asset Utilization Ratio (2014 - 2020) Analysis & Trends

Armata Pharmaceuticals (ARMP) has 5 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q2 2020.

For the quarter ending Q2 2020, Asset Utilization Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Jun 2020 stood at 0.0 (changed N/A YoY), and the FY2017 full-year result was 0.01, down 25.03% from the prior year.
Asset Utilization Ratio retreated to 0.0 in Q2 2020, from 0.01 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q2 2016 to a low of 0.0 in Q2 2020.
A 3-year average of 0.01 and a median of 0.01 in 2017 frame the typical range for Asset Utilization Ratio.
Across the five-year window, Asset Utilization Ratio jumped 53.3% in 2016 and tumbled 55.98% in 2017, its largest moves.
Tracing ARMP's Asset Utilization Ratio over 3 years: stood at 0.01 in 2016, then dropped by 21.57% to 0.01 in 2017, then slumped by 72.9% to 0.0 in 2020.
Business Quant data shows ARMP's Asset Utilization Ratio at 0.0 in Q2 2020, 0.01 in Q4 2017, and 0.01 in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.69
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	0.47
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.37
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Armata Pharmaceuticals	191.29 Mn	186.49 Mn	-	-

Download Data